Hematopoietic Stem Cell TransplantationTransplantation, HomologousStem Cell TransplantationHematopoietic Stem CellsStem CellsGraft vs Host DiseaseTransplantation ConditioningCell SurvivalTransplantation, AutologousHematologic NeoplasmsPeripheral Blood Stem Cell TransplantationTransplantation ChimeraBone Marrow TransplantationTreatment OutcomeGraft vs Leukemia EffectTissue DonorsMyeloablative AgonistsBusulfanMesenchymal Stem Cell TransplantationGraft SurvivalRemission InductionRecurrenceVidarabineCell DifferentiationGraft vs Tumor EffectSurvival RateHematopoietic Stem Cell MobilizationHistocompatibility TestingLeukemiaCord Blood Stem Cell TransplantationEmbryonic Stem CellsAntigens, CD34Leukemia, Myeloid, AcuteDisease-Free SurvivalRetrospective StudiesLymphocyte TransfusionCell ProliferationWhole-Body IrradiationImmunosuppressive AgentsAdult Stem CellsMesenchymal Stromal CellsMultiple MyelomaHematopoiesisSurvival AnalysisCombined Modality TherapyLeukemia, Myelogenous, Chronic, BCR-ABL PositiveCells, CulturedSiblingsCytomegalovirus InfectionsMyelodysplastic SyndromesStem Cell NicheHistocompatibilityBone Marrow CellsChimerismSalvage TherapyMinor Histocompatibility AntigensTime FactorsLymphocyte DepletionAntilymphocyte SerumPrecursor Cell Lymphoblastic Leukemia-LymphomaLiver TransplantationCell LineageNeoplasm, ResidualVirus ActivationMelphalanPluripotent Stem CellsHepatic Veno-Occlusive DiseaseNeoplastic Stem CellsFlow CytometryT-LymphocytesCyclophosphamideAntineoplastic Combined Chemotherapy ProtocolsMice, Inbred C57BLCell TransplantationHematologic DiseasesBone MarrowCytomegalovirusAnemia, AplasticAcute DiseaseHLA AntigensFollow-Up StudiesPrimary MyelofibrosisMultipotent Stem CellsApoptosisNeural Stem CellsStem Cell FactorSignal TransductionGranulocyte Colony-Stimulating FactorPrognosisInduced Pluripotent Stem CellsAntineoplastic AgentsColony-Forming Units AssayLeukemia, MyeloidTransplantation ImmunologyCell SeparationKidney TransplantationFetal BloodImmunocompromised HostCytarabineImmunosuppression